4.0 Review

Clinical implications for cannabinoid use in the rheumatic diseases: Potential for help or harm?

Journal

ARTHRITIS AND RHEUMATISM
Volume 64, Issue 8, Pages 2417-2425

Publisher

WILEY
DOI: 10.1002/art.34522

Keywords

-

Categories

Funding

  1. Eli Lilly
  2. Janssen
  3. Pfizer
  4. Purdue Pharma

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available